Photo: Elizabeth Frantz/Reuters Anthropic is finalizing a $3.5 billion funding round that values the startup behind the chatbot Claude at $61.5 billion, showing how eager investors are to back ...

Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.

Channel 5 has rebranded to ‘5’ across its linear, streaming and digital platforms in a move aimed at strengthening perceptions of its content quality and range. The change, effective today (12 March), ...

While the Baltimore Ravens try to find out which players from other teams might help them in 2025, they also need to pin down one of their own best players. Also, they need to score an A in the draft.

Your browser does not support the audio element. The MG Comet Blackstorm edition has been launched at a price of Rs 7.80 lakh (ex-showroom), plus Rs 2.50 per km for ...

Well, here is what the Giants’ five-round post-combine 2025 NFL mock draft ... His lack of size and length at 5-9 and 193 pounds, Huzzie probably will be limited to a nickel back role in the ...

With the emergence and approval of other new oral anticoagulants such as dabigatran and rivaroxaban, the role of and place in therapy for all of these new agents will have to be clearly delineated.

The first seven-seat SUV sold by MG in Australia – the 2025 MG QS – has been revealed in government documents ahead of a local showroom arrival due by the middle of this year. But whereas the ...

Some prospects are already clear first-round talents, but others come in with something to prove. To get a sense of how the board stacks up ahead of the workouts, I'm projecting all 32 picks in ...

Justin Thomas shot 1-over par on the third day of the 2025 Players Championship, following his record-tying 10-under par performance in the second round ... holes 2 through 5, but bogeyed No ...

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

For 2025, Altria expects its adjusted EPS to grow 2% to 5%. It plans to keep expanding its smokeless business with Njoy, its On nicotine pouches (which are now separately managed by its Helix ...